|
End-of-day quote
Cinnober Boat
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
| 09-14 | European Medical Solutions Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-22 | Danone, Eurofins Scientific, FDJ, Rexel, Vusion... stocks to watch today in Paris |  |
Company Valuation: ASIT biotech
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4.86 | 4.904 | 82.82 | 35.01 | 25.39 | 22.01 |
| Change | - | 0.9% | 1,588.91% | -57.73% | -27.47% | -13.33% |
| Enterprise Value (EV) 1 | 7.664 | 7.64 | 93.38 | 49.58 | 40.66 | 35.79 |
| Change | - | -0.32% | 1,122.23% | -46.9% | -17.98% | -11.97% |
| P/E | -3.57x | 1.26x | -14.8x | -47x | 46.5x | 12x |
| PBR | -0.86x | -2.84x | 7.84x | 3.57x | 2.46x | 1.82x |
| PEG | - | -0x | 0x | 0.5x | -0x | 0x |
| Capitalization / Revenue | 13.5x | 11,817x | 2.24x | 0.82x | 0.53x | 0.42x |
| EV / Revenue | 21.4x | 18,409x | 2.52x | 1.17x | 0.85x | 0.68x |
| EV / EBITDA | -14.9x | 1.96x | -45.4x | 840x | 30.9x | 12.2x |
| EV / EBIT | -12.1x | 1.97x | -40.4x | -367x | 32.4x | 14.3x |
| EV / FCF | -7.32x | -4.31x | -142x | -10.8x | -11.8x | 23.7x |
| FCF Yield | -13.7% | -23.2% | -0.71% | -9.25% | -8.48% | 4.22% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -21.9 | 62.63 | -1.318 | -0.176 | 0.129 | 0.4348 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 0.3589 | 0.000415 | 37.06 | 42.52 | 47.91 | 52.8 |
| EBITDA 1 | -0.5147 | 3.894 | -2.055 | 0.059 | 1.315 | 2.934 |
| EBIT 1 | -0.6317 | 3.881 | -2.311 | -0.135 | 1.255 | 2.501 |
| Net income 1 | -1.362 | 3.895 | -5.578 | -0.709 | 0.546 | 1.84 |
| Net Debt 1 | 2.804 | 2.736 | 10.56 | 14.57 | 15.27 | 13.79 |
| Reference price 2 | 78.144 | 78.848 | 19.571 | 8.272 | 6.000 | 5.200 |
| Nbr of stocks (in thousands) | 62.2 | 62.2 | 4,232 | 4,232 | 4,232 | 4,232 |
| Announcement Date | 4/30/21 | 4/30/22 | 4/28/23 | 4/21/24 | 4/14/25 | 4/14/26 |
1EUR in Million2EUR
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 12.67x | 0.39x | 8.18x | 3.05% | 111B | |
| 14.58x | 1.82x | 9.12x | 0.72% | 93.45B | |
| -297.15x | 20.17x | -349.04x | -.--% | 59.75B | |
| 13.49x | 1.48x | 8.94x | 2.65% | 28.21B | |
| 22.83x | 2.55x | 12.94x | 1.42% | 25.6B | |
| 22.16x | 2.05x | 11.73x | 0.94% | 25.04B | |
| 7.82x | 1.42x | 6.43x | -.--% | 20.74B | |
| 30.23x | 5.48x | 22.83x | 2.31% | 20.45B | |
| 30.77x | 2.88x | 12.95x | 1.46% | 17.03B | |
| Average | -15.84x | 4.25x | -28.44x | 1.4% | 44.63B | |
| Weighted average by Cap. | -30.26x | 4.40x | -43.30x | 1.53% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALEMS Stock
- 0RGO Stock
- Valuation ASIT biotech
Select your edition
All financial news and data tailored to specific country editions
